# Rapport Therapeutics, Inc.: Form 8-K, filed Jun 10, 2026

- Company: [Rapport Therapeutics, Inc.](/companies/rapp.md) (CIK 2012593)
- Form: 8-K
- Filed: 2026-06-10
- Accepted by EDGAR: Jun 10, 2026, 16:12 ET
- Period: 2026-06-10
- Accession: 0001193125-26-265841
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2012593/000119312526265841/rapp-20260610.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2012593/000119312526265841/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2012593/000119312526265841/rapp-20260610.htm

Filed Jun 10, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-265841. Last ingested by Listed: Nov 4, 2026, 07:39 ET. No prices; not investment advice.
